beta-Sitosterol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
beta-Sitosterol
Accession Number
DB14038
Type
Small Molecule
Groups
Experimental
Description

Active fraction of Solanum trilobatum; reduces side-effects of radiation-induced toxicity.

Structure
Thumb
Synonyms
  • (-)-β-Sitosterol
  • (24R)-Ethylcholest-5-en-3beta-ol
  • (24R)-ethylcholest-5-en-3β-ol
  • (24R)-Stigmast-5-en-3beta-ol
  • (3β)-Stigmast-5-en-3-ol
  • 22,23-Dihydrostigmasterol
  • 24α-Ethylcholesterol
  • Azuprostat
  • Cupreol
  • Nimbosterol
  • Sitosterol
  • Triastonal
  • α-Dihydrofucosterol
  • β-Sitosterin
External IDs
SKF 14463
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
InsadolTablet35 mg/1OralOASIS TRADING2018-11-20Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Insadolbeta-Sitosterol (35 mg/1)TabletOralOASIS TRADING2018-11-20Not applicableUs
Mi-Omega NFbeta-Sitosterol (200 mg/1) + Cyanocobalamin (500 ug/1) + Folic acid (1 mg/1) + Omega-3-acid ethyl esters (500 mg/1) + Pyridoxine hydrochloride (12.5 mg/1)CapsuleOralMayne Pharma2009-01-012016-05-31Us
International/Other Brands
Harzol
Categories
UNII
S347WMO6M4
CAS number
83-46-5
Weight
Average: 414.718
Monoisotopic: 414.38616623
Chemical Formula
C29H50O
InChI Key
KZJWDPNRJALLNS-VJSFXXLFSA-N
InChI
InChI=1S/C29H50O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h10,19-21,23-27,30H,7-9,11-18H2,1-6H3/t20-,21-,23+,24+,25-,26+,27+,28+,29-/m1/s1
IUPAC Name
(1R,3aS,3bS,7S,9aR,9bS,11aR)-1-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol
SMILES
[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CC[C@@H](CC)C(C)C

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Human Metabolome Database
HMDB0000852
KEGG Drug
D08518
KEGG Compound
C01753
ChemSpider
192962
BindingDB
50218197
ChEBI
27693
ChEMBL
CHEMBL221542
Wikipedia
Beta-Sitosterol

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1, 2Not Yet RecruitingTreatmentGraft Pain / Recession, Gingival1
2CompletedTreatmentPeriodontitis, Chronic1
Not AvailableCompletedBasic ScienceHigh Cholesterol / Indication for Carotid Endarterectomy / Symptomatic Carotid Stenosis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
TabletOral35 mg/1
CapsuleOral
Capsule, coatedOral
Capsule, gelatin coatedOral
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility1.84e-05 mg/mLALOGPS
logP7.27ALOGPS
logP7.84ChemAxon
logS-7.4ALOGPS
pKa (Strongest Acidic)18.2ChemAxon
pKa (Strongest Basic)-1.4ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area20.23 Å2ChemAxon
Rotatable Bond Count6ChemAxon
Refractivity129.77 m3·mol-1ChemAxon
Polarizability54.21 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleYesChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (1 TMS)GC-MSsplash10-054k-3912000000-22f633cd1bdd2ecca960
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
GC-MS Spectrum - EI-BGC-MSsplash10-0aor-9810000000-ab4d6cb3490b23c5cb70
GC-MS Spectrum - EI-BGC-MSsplash10-03di-5947700000-fe0573c7669e97c469f5
GC-MS Spectrum - EI-BGC-MSsplash10-0002-2931000000-0d63e91b728deb1446a4
GC-MS Spectrum - EI-BGC-MSsplash10-0a4l-9822000000-2be95863c114e7cd2597
GC-MS Spectrum - EI-BGC-MSsplash10-0a4l-9601000000-edade780f6cfb8ddc7d1
GC-MS Spectrum - GC-MSGC-MSsplash10-054k-3912000000-22f633cd1bdd2ecca960
Mass Spectrum (Electron Ionization)MSsplash10-052f-9821000000-0f43ba6def9281d5c86d
MS/MS Spectrum - Quattro_QQQ 10V, PositiveLC-MS/MSsplash10-014i-0002900000-f2b81675160568c483c5
MS/MS Spectrum - Quattro_QQQ 25V, PositiveLC-MS/MSsplash10-05nb-3930100000-897e65b10be8a412585c
MS/MS Spectrum - Quattro_QQQ 40V, PositiveLC-MS/MSsplash10-0a59-6900000000-b62b8d1bd807fc41256b
MS/MS Spectrum - EI-B (VARIAN MAT-44) , PositiveLC-MS/MSsplash10-0aor-9810000000-fcbfd841778e213b3d3e
MS/MS Spectrum - EI-B (HITACHI M-52) , PositiveLC-MS/MSsplash10-03di-5947700000-4234b723ccdb0e25d290
MS/MS Spectrum - EI-B (SHIMADZU LKB-9000B) , PositiveLC-MS/MSsplash10-0002-2931000000-b2156fbd63c29312b076
MS/MS Spectrum - EI-B (HITACHI M-80) , PositiveLC-MS/MSsplash10-0a4l-9822000000-2be95863c114e7cd2597
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
1H NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable

Taxonomy

Classification
Not classified

Drug created on May 17, 2018 14:50 / Updated on September 02, 2019 20:11